3-39143135-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033027.4(CSRNP1):c.1690G>A(p.Ala564Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033027.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSRNP1 | NM_033027.4 | c.1690G>A | p.Ala564Thr | missense_variant | Exon 5 of 5 | ENST00000273153.10 | NP_149016.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSRNP1 | ENST00000273153.10 | c.1690G>A | p.Ala564Thr | missense_variant | Exon 5 of 5 | 1 | NM_033027.4 | ENSP00000273153.5 | ||
CSRNP1 | ENST00000514182.1 | c.1690G>A | p.Ala564Thr | missense_variant | Exon 5 of 5 | 1 | ENSP00000422532.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250784Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135708
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461598Hom.: 0 Cov.: 30 AF XY: 0.0000454 AC XY: 33AN XY: 727046
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1690G>A (p.A564T) alteration is located in exon 5 (coding exon 4) of the CSRNP1 gene. This alteration results from a G to A substitution at nucleotide position 1690, causing the alanine (A) at amino acid position 564 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at